- Home
- ASRV vs FGEN Comparison
ASRV vs FGEN Comparison
Compare ASRV & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRV
- FGEN
- Stock Information
- Founded
- ASRV 1983
- FGEN 1993
- Country
- ASRV United States
- FGEN United States
- Employees
- ASRV N/A
- FGEN N/A
- Industry
- ASRV Major Banks
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- ASRV Finance
- FGEN Health Care
- Exchange
- ASRV Nasdaq
- FGEN Nasdaq
- Market Cap
- ASRV 40.1M
- FGEN 33.5M
- IPO Year
- ASRV N/A
- FGEN 2014
- Fundamental
- Price
- ASRV $2.81
- FGEN $0.29
- Analyst Decision
- ASRV
- FGEN Strong Buy
- Analyst Count
- ASRV 0
- FGEN 1
- Target Price
- ASRV N/A
- FGEN $10.00
- AVG Volume (30 Days)
- ASRV 21.7K
- FGEN 727.7K
- Earning Date
- ASRV 07-15-2025
- FGEN 05-12-2025
- Dividend Yield
- ASRV 4.30%
- FGEN N/A
- EPS Growth
- ASRV N/A
- FGEN N/A
- EPS
- ASRV 0.22
- FGEN N/A
- Revenue
- ASRV $53,037,000.00
- FGEN $6,996,000.00
- Revenue This Year
- ASRV N/A
- FGEN $232.81
- Revenue Next Year
- ASRV N/A
- FGEN $9.16
- P/E Ratio
- ASRV $12.97
- FGEN N/A
- Revenue Growth
- ASRV 16.87
- FGEN N/A
- 52 Week Low
- ASRV $2.03
- FGEN $0.18
- 52 Week High
- ASRV $3.06
- FGEN $1.53
- Technical
- Relative Strength Index (RSI)
- ASRV 79.00
- FGEN 39.43
- Support Level
- ASRV $2.64
- FGEN $0.29
- Resistance Level
- ASRV $2.67
- FGEN $0.34
- Average True Range (ATR)
- ASRV 0.10
- FGEN 0.02
- MACD
- ASRV 0.03
- FGEN -0.00
- Stochastic Oscillator
- ASRV 97.46
- FGEN 0.00
About ASRV AmeriServ Financial Inc.
AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking and it generates maximum revenue. The community banking segment includes both retail and commercial banking activities. The company also offers retail banking which includes the deposit-gathering branch franchise and lending to both individuals and small businesses; Lending activities include residential mortgage loans, direct consumer loans, and small business commercial loans; Commercial banking to businesses includes commercial loans, business services, and CRE loans.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.